2023 Form 5500 filing — Aclaris Therapeutics Inc 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241014091723NAL0025804065001) for Aclaris Therapeutics Inc 401(K) Plan, reported by Aclaris Therapeutics Inc under EIN 46-0571712 and plan number 001. It reports 154 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241014091723NAL0025804065001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Aclaris Therapeutics Inc
- EIN
- 46-0571712
- Plan number
- 001
- Location
- Wayne, PA
- Participants
- 154
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $12,430,834
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $12,430,834
- Employer contributions
- $707,520
- Participant contributions
- $1,712,221
- Total income / additions
- $4,675,015
- Benefits paid
- $1,553,142
- Administrative expenses
- $32,815
- Total expenses
- $1,590,228
- Net increase / (decrease)
- $3,084,787
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| T. Rowe Price Rps, Inc. | NONE | $32,815 | $0 |
| Pimco Funds | NONE | $0 | $0 |
| Alliance Global Funds | NONE | $0 | $0 |
| Prudential Jennison | NONE | $0 | $0 |
| American Funds | NONE | $0 | $0 |
| Tiaa-Cref Funds | NONE | $0 | $0 |
| Fidelity | NONE | $0 | $0 |
| Principal Funds | NONE | $0 | $0 |
| Jp Morgan Funds | NONE | $0 | $0 |
| Janus Funds | NONE | $0 | $0 |